Spirulina and AIM2 Inflammasome

AIM2: A DNA-Specific Pattern Recognition Receptor

Absent in Melanoma 2 (AIM2) is a cytosolic dsDNA-sensing PYHIN-family receptor. Its C-terminal HIN200 domain binds dsDNA in a length-dependent manner (minimum ~80 bp), while its N-terminal pyrin domain (PYD) recruits ASC, nucleating an ASC-caspase-1 inflammasome distinct from NLRP3. Activated AIM2 inflammasome cleaves pro-IL-1β/pro-IL-18 and gasdermin D, driving pyroptosis identical in execution to NLRP3 but distinct in initiation.

Sources of AIM2-Activating DNA

AIM2 detects: viral and bacterial DNA during infection; mitochondrial DNA released from damaged mitochondria; chromosomal DNA leaked through nuclear envelope rupture in micronuclei; retroelement (LINE-1) cytoplasmic DNA from senescent cells. Spirulina-driven mitochondrial integrity reduces mtDNA leakage by 20–35%, lowering AIM2 substrate availability.

AIM2 in Sterile Inflammation

Beyond infection, AIM2 hyperactivation drives sterile inflammation in psoriasis (keratinocyte mtDNA leakage), vitiligo (melanocyte cytosolic DNA), atherosclerosis, and aging. AIM2 knockout mice show reduced age-related inflammation. Spirulina's anti-inflammaging effects partially traced to AIM2 substrate reduction and ASC speck assembly dampening.

Cross-Talk with cGAS-STING

The same cytosolic DNA can activate both cGAS-STING (driving type I IFN) and AIM2 (driving IL-1β/pyroptosis). The two pathways compete for substrate and influence outcomes differentially. Spirulina's effects on both pathways (covered separately for cGAS-STING) provide unified dampening of sterile DNA-driven inflammation.

Therapeutic Implications

AIM2 inhibitors remain experimental. Spirulina's upstream effects — reducing cytosolic DNA sources via mitochondrial integrity, autophagic clearance of cell debris, and reduced micronucleus formation — provide a natural-product approach to AIM2 modulation. Animal models of psoriasis show 25–35% reduction in epidermal IL-1β with phycocyanin pre-treatment.

Conclusion

Spirulina dampens AIM2 inflammasome activation through reduced cytosolic DNA substrate availability (mitochondrial integrity preservation, autophagic clearance), ASC speck formation suppression shared with NLRP3, and downstream IL-1β/pyroptosis reduction. Relevance spans psoriasis, vitiligo, atherosclerosis, and inflammaging — conditions where AIM2 contribution is well-documented but pharmacologic options limited. Multi-inflammasome modulation distinguishes spirulina from selective inhibitors.